menu
    • menu
    [{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Protein","year":"2014","type":"Inapplicable","leadProduct":"Creatine","moa":"Creatine kinase M-type; Creatine kinase U-type, mitochondrial; Creatine kinase B-type; Creatine kinase S-type, mitochondrial; Sodium- and chloride-dependent creatine transporter 1; Guanidinoacetate N-methyltransferase","graph1":"Undisclosed","graph2":"Phase I","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Powder","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"University of Regina","sponsor":"Iovate Health Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"CANADA","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Creatine","moa":"Creatine kinase M-type; Creatine kinase U-type, mitochondrial; Creatine kinase B-type; Creatine kinase S-type, mitochondrial; Sodium- and chloride-dependent creatine transporter 1; Guanidinoacetate N-methyltransferase","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"University of Regina","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Regina \/ Iovate Health Sciences","highestDevelopmentStatusID":"1","companyTruncated":"University of Regina \/ Iovate Health Sciences"},{"orgOrder":0,"company":"University of Regina","sponsor":"Iovate Health Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CANADA","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Creatine","moa":"Creatine kinase M-type; Creatine kinase U-type, mitochondrial; Creatine kinase B-type; Creatine kinase S-type, mitochondrial; Sodium- and chloride-dependent creatine transporter 1; Guanidinoacetate N-methyltransferase","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"University of Regina","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Regina \/ Iovate Health Sciences","highestDevelopmentStatusID":"1","companyTruncated":"University of Regina \/ Iovate Health Sciences"},{"orgOrder":0,"company":"University of Sao Paulo","sponsor":"AlzChem AG","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"BRAZIL","productType":"Protein","year":"2011","type":"Inapplicable","leadProduct":"Creatine","moa":"Creatine kinase M-type; Creatine kinase U-type, mitochondrial; Creatine kinase B-type; Creatine kinase S-type, mitochondrial; Sodium- and chloride-dependent creatine transporter 1; Guanidinoacetate N-methyltransferase","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"University of Sao Paulo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Sao Paulo \/ AlzChem AG","highestDevelopmentStatusID":"1","companyTruncated":"University of Sao Paulo \/ AlzChem AG"}]

    Find Clinical Drug Pipeline Developments & Deals for 2-[carbamimidoyl(methyl)amino]acetic acid

    Menu

    2-[carbamimidoyl(methyl)amino]acetic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University of Regina

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            University of Regina

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Creatine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Iovate Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Resistance-band Training and Creatine Supplementation Strategies in Healthy Older Adults

                            Details : Creatine is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            September 23, 2024

                            Lead Product(s) : Creatine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Iovate Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            University of Regina

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            University of Regina

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Creatine

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Undisclosed

                            Sponsor : Iovate Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Creatine Supplementation in Young Healthy Adults

                            Details : Creatine is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Muscle Cramp.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            September 20, 2024

                            Lead Product(s) : Creatine

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Undisclosed

                            Sponsor : Iovate Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            GSK

                            United Kingdom arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            GSK

                            United Kingdom arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Creatine

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Fun...

                            Details : Creatine is a Protein drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            February 10, 2014

                            Lead Product(s) : Creatine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            University of Sao Paulo

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            University of Sao Paulo

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Creatine

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : AlzChem AG

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Creatine on Bone Mass in Postmenopausal Women

                            Details : Creatine is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            November 16, 2011

                            Lead Product(s) : Creatine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : AlzChem AG

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth